These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7011759)

  • 1. Specific antibodies and Fab fragments to alter the pharmacokinetics and reverse the pharmacologic/toxicologic effects of drugs.
    Colburn WA
    Drug Metab Rev; 1980; 11(2):223-62. PubMed ID: 7011759
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of drugs during various detoxification procedures for overdose and environmental exposure.
    Holazo AA; Colburn WA
    Drug Metab Rev; 1982; 13(4):715-43. PubMed ID: 7128457
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of xenobiotic elimination: role of intestinal excretion.
    Israili ZH; Dayton PG
    Drug Metab Rev; 1984; 15(5-6):1123-59. PubMed ID: 6396054
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics in patients with renal failure.
    Maher JF
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free and total serum digoxin concentrations in a renal failure patient after treatment with digoxin immune Fab.
    Clifton GD; McIntyre WJ; Zannikos PN; Harrison MR; Chandler MH
    Clin Pharm; 1989 Jun; 8(6):441-5. PubMed ID: 2743737
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies as specific antagonists of toxins, drugs, and hormones.
    Butler VP
    Pharmacol Rev; 1982 Mar; 34(1):109-14. PubMed ID: 7041142
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats.
    Pentel PR; Keyler DE; Gilbertson DG; Ruth G; Pond SM
    Drug Metab Dispos; 1988; 16(1):141-5. PubMed ID: 2894943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
    Sabouraud AE; Urtizberea M; Cano NJ; Grandgeorge M; Rouzioux JM; Scherrmann JM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1214-9. PubMed ID: 1545388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
    Smith TW; Lloyd BL; Spicer N; Haber E
    Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of phencyclidine (PCP) pharmacokinetics with PCP-specific Fab fragments.
    Owens SM; Mayersohn M
    NIDA Res Monogr; 1986; 64():112-26. PubMed ID: 3086729
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy of drug poisoning].
    Sabouraud A; Scherrmann JM
    Therapie; 1994; 49(1):41-8. PubMed ID: 7832846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the pharmacokinetics of drugs in renal failure].
    Nadzhimutdinov KN; Krakovskiĭ ME
    Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.
    Butler VP; Schmidt DH; Smith TW; Haber E; Raynor BD; Demartini P
    J Clin Invest; 1977 Feb; 59(2):345-59. PubMed ID: 299860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs.
    Owens SM; Mayersohn M
    Drug Metab Dispos; 1986; 14(1):52-8. PubMed ID: 2868866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of renal excretory insufficiency on pharmacokinetics and dosage of drugs].
    Kokot F
    Przegl Lek; 1982; 39(7):453-67. PubMed ID: 7178517
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, pharmacokinetics, and toxicokinetics defined.
    Di Carlo FJ
    Drug Metab Rev; 1982; 13(1):1-4. PubMed ID: 7084027
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extraction of drugs by dialysis].
    Singlas E; Lebelle AV
    Therapie; 1987; 42(6):529-40. PubMed ID: 3327192
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
    Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.